Drug Screening Market Remains Strong Despite Economic Uncertainty - Exclusive Report by MarketsandMarkets™
The global market is projected to reach USD 11.6 billion by 2026, from USD 5.3 billion in 2021, at a CAGR of 16.8% during the forecast period.

Drug screening is becoming increasingly important due to the growing prevalence of drug abuse and drug-related crimes. Drug screening helps to identify individuals who may have used illegal drugs and to monitor individuals who are receiving drug treatment. Drug screening is also used to detect the presence of drugs in an individual's system during pre-employment screening. This helps employers make informed hiring decisions and helps to reduce the costs associated with drug-related accidents and drug-related employee absenteeism.

The market is anticipated to witness a significant growth over the forecast period, owing to factors such as the increasing incidence of substance abuse and the increasing demand for drug testing in workplaces.

Download an Illustrative overview @

The increasing prevalence of illicit drug use has increased the demand for drug testing in workplaces, educational institutions, and other public and private venues. This is expected to drive the demand for drug screening products and services in the coming years. Additionally, the increasing awareness of the dangers of drug addiction, the rising acceptance of drug testing at workplaces, and the increasing implementation of drug testing policies in various sectors are some of the factors that are expected to spur the growth of the drug screening market.

The Drug Screening Market 2021-2026 Key Highlights:


• It covers evaluations at the national and regional levels.

• Recommendations and methods for newcomers

• Industry drivers, constraints, possibilities, risks, difficulties, asset management, and ideas.

• It shows information in a written and graphic format that is easy to interpret and compare.

• Drug Screening Market changes are dynamic, such as market expansions, partnerships, market penetration, and mergers.


The market is segmented on the basis of product, end user, and region. On the basis of product, the market is bifurcated into immunoassay analyzers, chromatography instruments, rapid test kits, breathalyzers, and other products. Of these, the rapid test kits segment is expected to witness the highest growth over the forecast period, owing to their cost effectiveness, ease of use, and rapid test results.

Reasons for Drug Screening: Pre-Employment, Post-Accident, Random

1. Pre-Employment: Employers may choose to screen applicants for drugs prior to hiring them to ensure that new employees are drug-free and that the workplace is kept safe and productive.

2. Post-Accident: Employers may require drug screenings after an accident occurs to determine whether drugs or alcohol may have played a role in the incident.

3. Random: Employers may choose to randomly test employees for drugs as part of their drug-free workplace policies in order to ensure safety and productivity.

Key Market Players

The drug screening market is highly competitive with the presence of several small and big players. Some of the players offering products for drug screening market include Abbott Laboratories (US), Thermo Fisher Scientific (US), Quest Diagnostics (US), Alfa Scientific Designs (US), Roche (Switzerland), OraSure Technologies (US), MPD Inc. (US), and Shimadzu (Japan). These companies are investing heavily in research and development to expand their product portfolios and gain a competitive edge in the market.


LabCorp (US): LabCorp is a leading player in the US drug screening services market. The company’s leading position is attributed to its wide drug testing portfolio, including over 4,800 tests. The company has a strong brand name and robust service portfolio, which provides drug screening services to managed care organizations, governmental agencies, healthcare providers, hospitals and health systems, employers, patients, consumers, contract research organizations, food and nutritional companies, and independent clinical laboratories.


Request Sample Pages:

The study categorizes the Drug screening market into the following segments and subsegments:

By Product and Service

  • Drug Screening Product
  • Analytical Instruments
  • Rapid Testing Devices
  • Oral Fluid Testing Devices
  • Consumables
  • Drug Screening Service

By  Sample Type

  • Urine Samples
  • Breath Samples
  • Oral Fluid Samples
  • Hair Samples
  • Other Samples

By End User

  • Drug Testing Laboratories
  • Workplaces
  • Criminal Justice and Law Enforcement Agencies
  • Hospitals
  • Drug Treatment Centers
  • Individual Users
  • Pain Management Centers
  • Schools and Colleges

By Region

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World 

Recent Developments

  • Quest Diagnostics and Select Health of South Carolina entered into an agreement to expand Select Health’s laboratory network for its Medicaid and Medicare-Medicaid dual-eligible enrollees and to enhance access to diagnostics information services for members.
  • LabCorp Entered into a multi-year agreement with Infirmary Health (US) to offer laboratory testing services in the eastern Gulf Coast.

Speak to Analyst:

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.